LSBio
IHC-plus™ PDCD1 / CD279 / PD-1 Antibody

Anti-PD1 antibody IHC of human skin. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 5 ug/ml.

IHC-plus™ PDCD1 / CD279 / PD-1 Antibody

Primary AntibodyLSBio Guarantee
Antibody:Rabbit Polyclonal
Applications:Enzyme-Linked Immunosorbent Assay, Immunofluorescence, Immunohistochemistry (general), Immunohistochemistry, Paraffin, Western Blot
Reactivity:Human, Mouse
Format:Liquid
See all PDCD1 / CD279 / PD-1 antibodies →
$470.00each
Catalog Number: LS-B540-0.05

For bulk orders or custom formulations:

Request a Quote

Overview

Description
PD-1 antibody LS-B540 is an unconjugated rabbit polyclonal antibody to PD-1 (PDCD1 / CD279) from human. It is reactive with human and mouse. Validated for ELISA, IF, IHC and WB. Tested on 20 paraffin-embedded human tissues. Cited in 1 publication.
Application
ELISA, IF, IHC, IHC-P, WB
Reactivity
Hu, Ms
Intended Use
Research Use Only
Guarantees
This product carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Polyclonal Antibodies
Alternative Names
CD279 | HPD-1 | HPD-l | PD1 | PDCD1 | Protein PD-1 | SLEB2 | PD-1 | CD279 antigen | Programmed cell death 1
Recommended Dilution: IHC-P
2.5 µg/ml
UniProt Number
Q15116
SwissProt
Q15116

Target

Target
PDCD1 / CD279 / PD-1
Antigen Species
Human
Gene Name
PDCD1

Antibody

Host Species
Rabbit
Clonality
Polyclonal
Origin Species
Human

Immunogen

Immunogen
A 16 AA synthetic peptide near the C-Terminus of human PD-1. The immunogen is located within aa 210-260 of PD-1.
Immunogen Type
Synthetic Peptide (Linear)

Format

Conjugate/Label
Unconjugated
Format
Liquid
Formulation
PBS containing 0.02% Sodium Azide
Concentration
1 mg/mL
Animal Free
No
Carrier-Free
Yes
Preservative
Yes
Purification Method
Affinity Purified

Storage & Handling

Storage Conditions
Store at 4°C for up 3 months. Store at -20°C for up to 1 year. Avoid freeze/thaw cycles.
Recommended Storage Buffer
PBS
Somatic Mutations and Immune Alternation in Rectal Cancer Following Neoadjuvant Chemoradiotherapy. Dengbo Ji , Haizhao Yi , Dakui Zhang , Tiancheng Zhan, Zhaowei Li, Ming Li, Jinying Jia, Meng Qiao, Jinhong Xia, Zhiwei Zhai, Can Song, Jin Gu. Cancer immunology research. 2018 Nov;6:1401-1416. PubMed: 30282671

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.